Northern Trust’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.68M Sell
370,674
-9,099
-2% -$90.4K ﹤0.01% 2643
2025
Q1
$3.6M Sell
379,773
-4,384
-1% -$41.6K ﹤0.01% 2599
2024
Q4
$5.3M Buy
384,157
+116,086
+43% +$1.6M ﹤0.01% 2474
2024
Q3
$4.08M Buy
268,071
+138,458
+107% +$2.11M ﹤0.01% 2596
2024
Q2
$618K Buy
129,613
+9,299
+8% +$44.4K ﹤0.01% 3426
2024
Q1
$817K Sell
120,314
-6,915
-5% -$47K ﹤0.01% 3401
2023
Q4
$622K Buy
127,229
+22,269
+21% +$109K ﹤0.01% 3467
2023
Q3
$359K Sell
104,960
-547
-0.5% -$1.87K ﹤0.01% 3609
2023
Q2
$504K Sell
105,507
-467
-0.4% -$2.23K ﹤0.01% 3543
2023
Q1
$447K Buy
105,974
+1,165
+1% +$4.92K ﹤0.01% 3518
2022
Q4
$405K Sell
104,809
-496
-0.5% -$1.92K ﹤0.01% 3571
2022
Q3
$631K Buy
105,305
+3,905
+4% +$23.4K ﹤0.01% 3437
2022
Q2
$354K Sell
101,400
-1,021
-1% -$3.56K ﹤0.01% 3659
2022
Q1
$351K Sell
102,421
-1,502
-1% -$5.15K ﹤0.01% 3878
2021
Q4
$304K Sell
103,923
-749
-0.7% -$2.19K ﹤0.01% 4010
2021
Q3
$421K Buy
104,672
+421
+0.4% +$1.69K ﹤0.01% 3827
2021
Q2
$535K Buy
104,251
+7,310
+8% +$37.5K ﹤0.01% 3683
2021
Q1
$453K Sell
96,941
-39,873
-29% -$186K ﹤0.01% 3844
2020
Q4
$469K Sell
136,814
-14,551
-10% -$49.9K ﹤0.01% 3742
2020
Q3
$795K Buy
151,365
+2,894
+2% +$15.2K ﹤0.01% 3486
2020
Q2
$683K Buy
+148,471
New +$683K ﹤0.01% 3471
2019
Q2
Sell
-4,592
Closed -$21K 4276
2019
Q1
$21K Sell
4,592
-30
-0.6% -$137 ﹤0.01% 4126
2018
Q4
$19K Buy
4,622
+30
+0.7% +$123 ﹤0.01% 4157
2018
Q3
$48K Hold
4,592
﹤0.01% 4140
2018
Q2
$62K Buy
4,592
+726
+19% +$9.8K ﹤0.01% 4090
2018
Q1
$53K Hold
3,866
﹤0.01% 4074
2017
Q4
$61K Buy
3,866
+2,157
+126% +$34K ﹤0.01% 4044
2017
Q3
$52K Hold
1,709
﹤0.01% 4054
2017
Q2
$14K Hold
1,709
﹤0.01% 4204
2017
Q1
$58K Buy
+1,709
New +$58K ﹤0.01% 4040